rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model
- PMID: 17495777
- DOI: 10.1097/BRS.0b013e318054721e
rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model
Abstract
Study design: The study design consisted of a New Zealand white rabbit model of pseudarthrosis repair. Study groups consisting of no graft, autograft, or recombinant human bone morphogenetic protein-2 (rhBMP-2) with absorbable collagen sponge (ACS) or compression resistant matrix (CRM) were evaluated.
Objective: To evaluate the relative efficacy of bone graft materials (autograft, ACS, and CRM).
Summary of background data: rhBMP-2 has been shown to have a 100% fusion rate in a primary rabbit fusion model, even in the presence of nicotine, which is known to inhibit fusion.
Methods: Seventy-two New Zealand white rabbits underwent posterolateral lumbar fusion with iliac crest autograft. To establish pseudarthroses, nicotine was administered to all animals. At 5 weeks, the spines were explored and all pseudarthroses were redecorticated and implanted with no graft, autograft, rhBMP-2/ACS, or rhBMP-2/CRM. At 10 weeks, fusions were assessed by manual palpation and histology.
Results: Eight rabbits (11%) were lost to complications. At 5 weeks, 66 (97%) had pseudarthroses. At 10 weeks, attempted pseudarthrosis repairs were fused in 1 of 16 of no graft rabbits (6%), 5 of 17 autograft rabbits (29%), and 31 of 31 rhBMP-2 rabbits (with ACS or CRM) (100%). Histologic analysis demonstrated more mature bone formation in the rhBMP-2 groups.
Conclusions: The 2 rhBMP-2 formulations led to significantly higher fusion rates and histologic bone formation than no graft and autograft controls in this pseudarthrosis repair model.
Similar articles
-
rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.Spine J. 2007 May-Jun;7(3):326-31. doi: 10.1016/j.spinee.2006.06.397. Epub 2006 Dec 22. Spine J. 2007. PMID: 17482116
-
Development of a New Zealand white rabbit model of spinal pseudarthrosis repair and evaluation of the potential role of OP-1 to overcome pseudarthrosis.Spine (Phila Pa 1976). 2004 Jul 1;29(13):1405-12. doi: 10.1097/01.brs.0000129028.25671.96. Spine (Phila Pa 1976). 2004. PMID: 15223930
-
B2A peptide on ceramic granules enhance posterolateral spinal fusion in rabbits compared with autograft.Spine (Phila Pa 1976). 2008 May 20;33(12):1324-9. doi: 10.1097/BRS.0b013e3181732a74. Spine (Phila Pa 1976). 2008. PMID: 18496344
-
Pseudomorbidity in iliac crest bone graft harvesting: the rise of rhBMP-2 in short-segment posterior lumbar fusion.Spine J. 2009 Nov;9(11):873-9. doi: 10.1016/j.spinee.2009.09.001. Spine J. 2009. PMID: 19850231 Review. No abstract available.
-
Graft options in posterolateral and posterior interbody lumbar fusion.Spine (Phila Pa 1976). 2010 Aug 1;35(17):1629-39. doi: 10.1097/BRS.0b013e3181d25803. Spine (Phila Pa 1976). 2010. PMID: 20628336 Review.
Cited by
-
The use of bone morphogenetic proteins (BMP) and pseudarthrosis, a literature review.Rev Bras Ortop. 2016 Jun 22;52(2):124-140. doi: 10.1016/j.rboe.2016.03.005. eCollection 2017 Mar-Apr. Rev Bras Ortop. 2016. PMID: 28409128 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials